Hyaluronic acid for the treatment of osteoarthritis in all joints except the Knee: What is the current evidence?

BioDrugs

Volumn 26, Issue 2, 2012, Pages 101-112

  Colen, Sascha ^a   Haverkamp, Daniel ^b   Mulier, Michiel ^a   Van Den Bekerom, Michel P J ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c Infection and Immunology   (Netherlands)

Author keywords

Hyaluronic acid; Joint disorders; Osteoarthritis.

Indexed keywords

BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; EUFLEXXA; FERMATHRON; HYALONE; HYALUBRIX; HYALURONIC ACID; MEPIVACAINE; METHYLPREDNISOLONE ACETATE; PLACEBO; SINOVIAL; SYNOCROM; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ANKLE; CONSERVATIVE TREATMENT; DRUG EFFICACY; ECHOGRAPHY; EVIDENCE BASED PRACTICE; FLUOROSCOPY; FROZEN SHOULDER; HIP OSTEOARTHRITIS; HUMAN; KINESIOTHERAPY; METATARSOPHALANGEAL JOINT; MOLECULAR WEIGHT; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; ROTATOR CUFF INJURY; SACROILIAC JOINT; SHOULDER; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADRENAL CORTEX HORMONES; HUMANS; HYALURONIC ACID; JOINTS; OSTEOARTHRITIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857813388     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11630830-000000000-00000     Document Type: Review

References (76)

1. Felson D. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988; 10: 1-28
2. Balazs E. The physical properties of the synovial fluid and the special role of hyaluronic acid. In: Helfet J, editor. Disorders of the knee. 2nd ed. Philidelphia: Lippincott, 1982: 61-74
3. Sostres C, Cargallo C, Arroyo M, et al. Adverse effects of non-steroidal antiinflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010; 24: 121-32
4. Brophy J. Cardiovascular effects of cyclooxygenase-2 inhibitors. Curr Opin Gastroenterol 2007; 23: 617-24
5. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16 (2): 137-62
6. Gibbs D, Merrill E, Smith K, et al. Rheology of hyaluronic acid. Biopolymeres 1968; 6: 777-91
7. Balazs E. Viscoelastic properties of hyaluronic acid and biological lubrification. Unic Mich Med Ctr J 1968; 9: 255-9
8. PunziL, SchiavonF,CavasinF, et al. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989; 7 (3): 247-50
9. Smith M, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987; 7: 113-22
10. Homandberg G, Hui F, Wen C, et al. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. in vitro. Osteoarthritis Cartilage 1997; 5 (5): 309-19
11. Williams J, Plaza V, Hui F, et al. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. in vivo. Osteoarthritis Cartilage 1997; 5 (4): 235-40
12. Belomonte C, Pozo M, Balazs E. Modulation by hyaluronan and its derivates (hylans) of sensory nerve activity signaling articular pain. In: Laurent T, editor. The chemistry, biology and medical applications of hyaluronan and its derivates. London: Portland Press, 1999: 205-17
13. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: Clinical and morphological study. Clin Exp Rheumatol 1998; 16: 441-9
14. Kikuchi T, Yamada H, Fujikawa K. Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 2001; 9: 351-6
15. Bagga H, Burkhardt D, Sambrook P, et al. Long-term effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006; 33: 946-50
16. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12
17. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1-12
18. Schulz KF, Chalmers I, Grimes DA, et al. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272: 125-8
19. Verhagen AP, De Vet HC, De Bie RA, et al. Balneotherapy and quality assessment: Interobserver reliability of the Maastricht criteria list and the need for blinded quality assessment. J Clin Epidemiol 1998; 51: 335-41
20. Mulrow CD, Oxman AD, editors. Cochrane Collaboration Handbook. In: The Cochrane Library [database on disk and CDROM]. Oxford: Cochrane Collaboration. Update Software: 1999
21. Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Clin Ther Res 1994; 55: 319-30
22. Brocq O, Tran G, Breuil V, et al. Hip osteoarthritis: Short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 2002; 69: 388-91
23. Migliore A, Martin LS, Alimonti A, et al. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003; 11 (4): 305-6
24. Vad VB, Sakalkale D, Sculco TP, et al. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 2003; 84 (8): 1224-6
25. Conrozier T, Bertin P, Mathieu P, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: An open-label, multicentre, pilot study. Clin Exp Rheumatol 2003; 21 (5): 605-10
26. Caglar-Yagci H, Unsal S, Yagci I, et al. Safety and efficacy of ultrasoundguided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: A pilot study. Rheumatol Int 2005; 25 (5): 341-4
27. Berg P, Olsson U. Intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) for osteoarthritis of the hip: A pilot study. Clin Exp Rheumatol 2004; 22: 300-6
28. Tikiz C, UnlüZ, Sener A, et al. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 2005; 24 (3): 244-50
29. Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 2005; 24 (10): 1391-5
30. Migliore A, Tormenta S, Valente C, et al. Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up. Reumatismo 2005; 57 (1): 36-43
31. Migliore A, Tormenta S, Massafra U, et al. Repeated ultrasound-guided intraarticular injections of 40 mg of Hyalgan® may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis Cartilage 2005; 13: 1126-7
32. Migliore A, Tormenta S, Martin LS, et al. Open pilot study of ultrasoundguided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 2005; 24: 285-9
33. Migliore A, Tormenta S, Martin LS, et al. The symptomatic effects of intraarticular administration of hylan G-F 20 on osteoarthritis of the hip: Clinical data of 6 months follow-up. Clin Rheumatol 2006; 25: 389-93
34. Van Den Bekerom MP, Mylle G, Rys B, et al. Viscosupplementation in symptomatic severe hip osteoarthritis: A review of the literature and report on 60 patients. Acta Orthop Belg 2006 Oct; 72 (5): 560-8
35. Conrozier T, Bertin P, Bailleul F, et al. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: The OMERACT- OARSI criteria applied to the results of a pilot study. Joint Bone Spine 2006; 73 (6): 705-9
36. Qvistgaard E, Christensen R, Torp-Pedersen S, et al. Intra-articular treatment of hip osteoarthritis: A randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006 Feb; 14 (2): 163-70
37. Migliore A, Tormenta S, Massafra U, et al. 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 2006; 58 (1): 39-49
38. Gaston MS, Tiemessen CH, Philips JE. Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: Efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 2007; 127 (10): 899-903
39. Migliore A, Tormenta S, Massafra U, et al. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: Tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 2008; 24 (5): 1309-16
40. Van den Bekerom MP, Rys B, Mulier M. Viscosupplementation in the hip: Evaluation of hyaluronic acid formulations. Arch Orthop Trauma Surg 2008 Mar; 128 (3): 275-80
41. Rennesson-Rey B, Rat AC, Chary-Valckenaere I, et al. Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? Joint Bone Spine 2008; 75 (2): 182-8
42. Diraçoǧ lu D, Alptekin K, Teksöz B, et al. Knee vs hip single-joint intraarticular hyaluronic acid injection in patients with both hip and knee osteoarthritis: A pilot study. Clin Rheumatol 2009; 28 (9): 1021-4
43. Richette P, Ravaud P, Conrozier T, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo-controlled trial. Arthritis Rheum 2009 Mar; 60 (3): 824-30
44. Conrozier T, Couris CM, Mathieu P, et al. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilizedhyaluronic- acid in the hip joint: Results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg 2009; 129 (6): 843-8
45. Migliore A, Massafra U, Bizzi E, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 2009; 11 (6): R183
46. Migliore A, Massafra U, Bizzi E, et al. Intra-articular injection of hyaluronic acid (MW 1.500-2.000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: A prospective cohort study. Arch Orthop Trauma Surg 2011; 131 (12): 1677-85
47. Atchia I, Kane D, Reed MR, et al. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 2011 Jan; 70 (1): 110-6
48. Leardini G, PerbelliniA,FranceschiniM, et al. Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 1988; 10 (5): 521-6
49. Silverstein E, Leger R, Shea KP. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: A preliminary study. Am J Sports Med 2007; 35 (6): 979-85
50. Blaine T, Moskowitz R, Udell J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: A randomized, controlled trial.Amulticenter study. J Bone Joint Surg Am 2008; 90 (5): 970-9
51. Noël E, Hardy P, Hagena FW, et al. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study. Joint Bone Spine 2009; 76 (6): 670-3
52. Brander VA, Gomberawalla A, Chambers M, et al. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: A prospective, pilot study. PM R 2010; 2 (4): 259-67
53. Tagliafico A, Serafini G, Sconfienza LM, et al. Ultrasound-guided viscosupplementation of subacromial space in elderly patients with cuff tear arthropathy using a high weight hyaluronic acid: Prospective open-label non-randomized trial. Eur Radiol 2011; 21 (1): 182-7
54. Salk RS, Chang TJ, D'Costa WF, et al. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: A controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 2006; 88 (2): 295-302
55. Sun SF, Chou YJ, Hsu CW, et al. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: A prospective study. Osteoarthritis Cartilage 2006; 14 (9): 867-74
56. Cohen MM, Altman RD, Hollstrom R, et al. Safety and efficacy of intraarticular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 2008; 29 (7): 657-63
57. Witteveen AG, Giannini S, Guido G, et al. A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 2008; 14 (3): 145-52
58. Karatosun V, Unver B, Ozden A, et al. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 2008; 26 (2): 288-94
59. Luciani D, Cadossi M, Tesei F, et al. Viscosupplementation for grade II osteoarthritis of the ankle: A prospective study at 18 months' follow-up. Chir Organi Mov 2008; 92 (3): 155-60
60. Witteveen AG, Sierevelt IN, Blankevoort L, et al. Intra-articular sodium hyaluronate injections in the osteoarthritic ankle joint: Effects, safety and dose dependency. Foot Ankle Surg 2010; 16 (4): 159-63
61. Mei-Dan O, Kish B, Shabat S, et al. Treatment of osteoarthritis of the ankle by intra-articular injections of hyaluronic acid: A prospective study. JAmPodiatr Med Assoc 2010; 100 (2): 93-100
62. Fuchs S, Mönikes R, Wohlmeiner A, et al. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthritis Cartilage 2006; 14 (1): 82-8
63. Stahl S, Karsh-Zafrir I, Ratzon N, et al. Comparison of intraarticular injection of depot corticosteroid and hyaluronic acid for treatment of degenerative trapeziometacarpal joints. J Clin Rheumatol 2005; 11 (6): 299-302
64. Coaccioli S, Pinoca F, Puxeddu A. Short term efficacy of intra-articular injection of hyaluronic acid in osteoarthritis of the first carpometacarpal joint in a preliminary open pilot study. Clin Ter 2006; 157 (4): 321-5
65. Karalezli N, Ogun TC, Kartal S, et al. The pain associated with intraarticular hyaluronic acid injections for trapeziometacarpal osteoarthritis. Clin Rheumatol 2007; 26 (4): 569-71
66. Roux C, Fontas E, Breuil V, et al. Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis: A prospective evaluation of efficacy. Joint Bone Spine 2007; 74 (4): 368-72
67. Heyworth BE, Lee JH, Kim PD, et al. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: A prospective, randomized, double-blinded clinical trial. J Hand Surg Am 2008; 33 (1): 40-8
68. Bahadir C, Onal B, Dayan VY, et al. Comparison of therapeutic effects of sodiumhyaluronate and corticosteroid injections on trapeziometacarpal joint osteoarthritis. Clin Rheumatol 2009; 28 (5): 529-33
69. Salini V, De Amicis D, Abate M, et al. Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: Short-term results. Int J Immunopathol Pharmacol 2009; 22 (2): 455-60
70. Mandl LA, Hotchkiss RN, Adler RS, et al. Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: Open label pilot trial. Curr Med Res Opin 2009; 25 (9): 2103-8
71. Fuchs S, Erbe T, Fischer HL, et al. Intraarticular hyaluronic acid versus glucocorticoid injections for nonradicular pain in the lumbar spine. J Vasc Interv Radiol 2005; 16 (11): 1493-8
72. Cleary M, Keating C, Poynton AR. Viscosupplementation in lumbar facet joint arthropathy: A pilot study. J Spinal Disord Tech 2008; 21 (1): 29-32
73. DePalma MJ, Ketchum JM, Queler ED, et al. Prospective pilot study of painful lumbar facet joint arthropathy after intra-articular injection of hylan G-F 20. PM R 2009; 1 (10): 908-15
74. Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: A new concept in the treatment of sacroiliac joint syndrome: A preliminary report of four cases. Reg Anesth Pain Med 1999; 24 (1): 84-8
75. Pons M, Alvarez F, Solana J, et al. Sodium hyaluronate in the treatment of hallux rigidus: A single-blind, randomized study. Foot Ankle Int 2007; 28 (1): 38-42
76. Colen S, van den Bekerom MP, Bellemans J, et al. Comparison of intraarticular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine: Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors. BMC Musculoskelet Disord 2010; 16 (11): 264